XML 53 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Oct. 31, 2019
Oct. 31, 2018
Cash flows from operating activities:    
Net loss $ (459,000) $ (2,768,000)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 113,000 411,000
Amortization of capitalized software development costs 644,000 895,000
Amortization of intangible assets 424,000 705,000
Amortization of other deferred costs 208,000 347,000
Valuation adjustments 48,000 71,000
Loss on exit of operating lease   1,368,000
Gain on disposal of fixed assets   5,000
Share-based compensation expense 719,000 492,000
Provision for accounts receivable (125,000) (24,000)
Changes in assets and liabilities:    
Accounts and contract receivables 1,455,000 591,000
Other assets (572,000) 272,000
Accounts payable (651,000) 1,049,000
Accrued expenses (442,000) 54,000
Deferred revenues (2,337,000) (4,176,000)
Net cash provided by operating activities (975,000) (708,000)
Cash flows from investing activities:    
Purchases of property and equipment (51,000) (21,000)
Proceeds from sales of property and equipment   20,000
Capitalization of software development costs (2,730,000) (2,288,000)
Net cash used in investing activities (2,781,000) (2,289,000)
Cash flows from financing activities:    
Proceeds from issuance of common stock 9,663,000  
Payments of costs directly attributable to the issuance of common stock (681,000)  
Principal payments on term loan (448,000) (448,000)
Payments related to settlement of employee shared-based awards (50,000) (62,000)
Redemption of Series A Preferred Stock (5,791,000)  
Fees paid for redemption of Series A Convertible Preferred Stock (22,000)  
Payment of deferred financing costs (73,000)  
Other 2,000 31,000
Net cash provided by (used in) financing activities 2,600,000 (479,000)
Net decrease in cash and cash equivalents (1,156,000) (3,476,000)
Cash and cash equivalents at beginning of period 2,376,000 4,620,000
Cash and cash equivalents at end of period $ 1,220,000 $ 1,144,000